Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monique Cherrier

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of the American Osteopathic Association|June 30, 2020
LETTER TO THE EDITORMonique Cherrier, Gregory Terman, Danny Shen, et al.
Journal of Psychoactive Drugs|August 21, 2007
An open-label pilot study of risperidone in the treatment of methamphetamine dependenceCharles W Meredith, Craig Jaffe, Elisia Yanasak, et al.
Journal of Addictive Diseases|September 28, 2005
A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatologyCraig Jaffe, Kristen R Bush, Kristy Straits-Troster, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 4, 2003
17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary studyLaura D Baker, Kumar Sambamurti, Suzanne Craft, et al.
Journal of Alzheimer'S Disease : JAD|July 24, 2009
Effects of insulin and octreotide on memory and growth hormone in Alzheimer's diseaseG Stennis Watson, Laura D Baker, Brenna A Cholerton, et al.
Neurology|August 20, 2017
Effect of simvastatin on CSF Alzheimer disease biomarkers in cognitively normal adultsGe Li, Cynthia L Mayer, Daniel Morelli, et al.
Journal of Addiction Medicine|July 20, 2011
Open trial of injectable risperidone for methamphetamine dependenceCharles W Meredith, Craig Jaffe, Monique Cherrier, et al.
Psychoneuroendocrinology|June 19, 2003
Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotypeSuzanne Craft, Sanjay Asthana, David G Cook, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of the American Osteopathic Association|June 30, 2020
LETTER TO THE EDITORMonique Cherrier, Gregory Terman, Danny Shen, et al.
Journal of Psychoactive Drugs|August 21, 2007
An open-label pilot study of risperidone in the treatment of methamphetamine dependenceCharles W Meredith, Craig Jaffe, Elisia Yanasak, et al.
Journal of Addictive Diseases|September 28, 2005
A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatologyCraig Jaffe, Kristen R Bush, Kristy Straits-Troster, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 4, 2003
17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary studyLaura D Baker, Kumar Sambamurti, Suzanne Craft, et al.
Journal of Alzheimer'S Disease : JAD|July 24, 2009
Effects of insulin and octreotide on memory and growth hormone in Alzheimer's diseaseG Stennis Watson, Laura D Baker, Brenna A Cholerton, et al.
Neurology|August 20, 2017
Effect of simvastatin on CSF Alzheimer disease biomarkers in cognitively normal adultsGe Li, Cynthia L Mayer, Daniel Morelli, et al.
Journal of Addiction Medicine|July 20, 2011
Open trial of injectable risperidone for methamphetamine dependenceCharles W Meredith, Craig Jaffe, Monique Cherrier, et al.
Psychoneuroendocrinology|June 19, 2003
Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotypeSuzanne Craft, Sanjay Asthana, David G Cook, et al.
Pageof 1